- SilverSun Technologies (NASDAQ:SSNT) +386% on acquiring Prairie Technology Solutions.
- Alterity Therapeutics (NASDAQ:ATHE) +221% on prospects of lead drug in rare neurological disorder.
- Zhongchao (NASDAQ:ZCMD) +33% on renewing contract with Johnson & Johnson.
- YRC Worldwide (NASDAQ:YRCW) +27% on Q2 results.
- Cocrystal Pharma (NASDAQ:COCP) +21% on announcing the publication of preclinical animal studies of coronavirus antiviral compounds.
- Ossen Innovation (NASDAQ:OSN) +22%.
- Danaos (NYSE:DAC) +21% on Q2 results.
- Sphere 3D (NASDAQ:ANY) +23%.
- CHF Solutions (NASDAQ:CHFS) +19% on Q2 results.
- Urban One (NASDAQ:UONE) +16%.
- Broadway Financial (NASDAQ:BYFC) +14%.
- Edison Nation (NASDAQ:EDNT) +13% on update on Edison Nation Medical’s sales activity with government customers.
- DURECT (NASDAQ:DRRX) +12%. after Q2 beat, launch of mid-stage study of DUR-928 in COVID-19.
- Carver Bancorp (NASDAQ:CARV) +12%.
- Verastem (NASDAQ:VSTM) +12%.
- Houston American Energy (NYSEMKT:HUSA) +11% on operational update.
- Eloxx Pharmaceuticals (NASDAQ:ELOX) +11% on receiving U.S. Orphan drug designation for ELX-02 for the treatment of Cystic Fibrosis.
- Professional Diversity Network (NASDAQ:IPDN) +11%.
- Sorrento Therapeutics (NASDAQ:SRNE) +10%.
- Tiziana Life Sciences (NASDAQ:TLSA) +9% on accelerated development plan for TZLS-501 in COVID-19.
- The Mosaic (NYSE:MOS) +9% on Q2 results.
- Urban One (NASDAQ:UONEK) +9%.
- Color Star Technology (NASDAQ:HHT) +7%.
- IMAC Holdings (NASDAQ:IMAC) +8%.
- MicroVision (NASDAQ:MVIS) +8%.